Citations

Citations to this article as recorded by  

• tGeCoNet: a framework for constructing temporal gene co-expression networks
  Pietro Cinaglia
  Neurocomputing.2026; 665: 132151.     CrossRef
• Attention-deficit/hyperactivity disorder-related psychomotor activity and altered neuronal activity in the medial prefrontal cortex and striatum in the A53T mouse model of Parkinson's disease and other synucleinopathies: Findings from an “endophenotype” a
  Olga Dubljević, Željko Pavković, Maja Srbovan, Milica Potrebić, Miloš Stanojlović, Vesna Pešić
  Progress in Neuro-Psychopharmacology and Biological Psychiatry.2025; 137: 111273.     CrossRef
• Clinical approach to monogenic Parkinson’s disease
  Manu S. Girija, Asha Kishore
  Annals of Movement Disorders.2025; 8(1): 1.     CrossRef
• Plasma and urinary metabolomic signatures differentiate genetic and idiopathic Parkinson’s disease
  Juliana Cordovil Cotrin, Gilson Costa dos Santos Junior, André Simões Cadaxo, Joao Santos Pereira, Mariana Spitz, Ana Lúcia Zuma de Rosso, Renato Peixoto Veras, Ana Paula Valente, Márcia Mattos Gonçalves Pimentel, Cíntia Barros Santos-Rebouças
  Brain Research.2025; 1858: 149625.     CrossRef
• RNA‐Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins
  Syed Arman Rabbani, Mohamed El‐Tanani, Shrestha Sharma, Yahia El‐Tanani, Rakesh Kumar, Manita Saini, Monu Yadav, Mohammad Ahmed Khan, Suhel Parvez
  European Journal of Neuroscience.2025;[Epub]     CrossRef
• Unlocking molecular secrets: The role of miRNAs in Parkinson's disease dynamics
  Rehab A. Ismail, Mohamed Abobakr, Mostafa Mohamed, Ahmed Hussieny, Mohamed Alaa, Mostafa tarek, Shereen Saeid Elshaer
  Neuropharmacology.2025; 278: 110542.     CrossRef
• α‐Synuclein Sequences from Long‐Lived Animals Display Generally Diminished Aggregation Compared to Shorter‐Lived Animals Including Humans
  Gilbert B. Ampomah, Eldon R. Hard, Matthew R. Pratt
  ChemBioChem.2025;[Epub]     CrossRef
• Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background
  Christos Koros, Evangelia Stanitsa, Efthalia Angelopoulou, Sokratis G. Papageorgiou, Leonidas Stefanis
  Biomedicines.2025; 13(7): 1624.     CrossRef
• Compound Heterozygous Structural Variants in Cases with Unsolved PRKN‐Associated Parkinson's Disease
  Agata Fant, Sara Trova, Edoardo Monfrini, Gaia Treves, Francesco Musacchia, Fabio Landuzzi, Paola Mandich, Antonio Amoroso, Remo Sanges, Luca Pandolfini, Francesco Cavallieri, Franco Valzania, Valentina Fioravanti, Giulia Di Rauso, Gloria Brescia, Enza Ma
  Movement Disorders.2025; 40(12): 2722.     CrossRef
• The APOE ε4 allele affects the survival of patients with Parkinson's disease independent of dementia
  Zheng Wang, Lu Li, Qian Xu, Hongxu Pan, Yijing Wang, Qin Long, Yuanfeng Huang, Yinghong Dai, Shiyu Zhang, Qiao Zhou, Guihu Zhao, Bin Li, Beisha Tang, Jian Qiu, Jinchen Li
  Journal of Translational Medicine.2025;[Epub]     CrossRef
• Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
  David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese
  Annals of Clinical and Translational Neurology.2025;[Epub]     CrossRef
• Maternal gut-microbiota impacts the influence of intrauterine environmental stressors on the modulation of human cognitive development and behavior
  Oluwatayo Israel Olasunkanmi, John Aremu, Ma-Li Wong, Julio Licinio, Peng Zheng
  Journal of Psychiatric Research.2024; 180: 307.     CrossRef
• Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics
  Yoonjeong Cha, Mohamedi N. Kagalwala, Jermaine Ross
  Pharmaceuticals.2024; 17(2): 158.     CrossRef
• The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson’s Disease: a New Genetic State of the Art
  Júlio César Claudino dos Santos, Gabriela Braga Cabrera Mano, André Rodrigues da Cunha Barreto-Vianna, Tulia Fernanda Meira Garcia, Aline Vieira de Vasconcelos, Caio Sérgio Gomes Sá, Sarah Lopes de Souza Santana, Ana Gabriela Ponte Farias, Beatriz Seimaru
  Molecular Neurobiology.2024; 61(9): 6754.     CrossRef
• Early Onset Parkinson’s Disease and It’s Genetic Consequences
  Hatice ÖMERCİKOĞLU ÖZDEN, Dilek GÜNAL
  OSMANGAZİ JOURNAL OF MEDICINE.2024;[Epub]     CrossRef
• Genotype–phenotype correlation in PRKN-associated Parkinson’s disease
  Poornima Jayadev Menon, Sara Sambin, Baptiste Criniere-Boizet, Thomas Courtin, Christelle Tesson, Fanny Casse, Melanie Ferrien, Louise-Laure Mariani, Stephanie Carvalho, Francois-Xavier Lejeune, Sana Rebbah, Gaspard Martet, Marion Houot, Aymeric Lanore, G
  npj Parkinson's Disease.2024;[Epub]     CrossRef
• Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives
  Jeanine Schulze, Jasmine Kaur Dhaliwal, Mandy Miller, Emily Quinn, Leah Wetherill, Lola Cook
  Movement Disorders Clinical Practice.2024; 11(7): 786.     CrossRef
• Disparities in Access to Deep Brain Stimulation for Parkinson’s Disease and Proposed Interventions: A Literature Review
  Anthony E. Bishay, Natasha C. Hughes, Michael Zargari, Danika L. Paulo, Steven Bishay, Alexander T. Lyons, Mariam N. Morkos, Tyler J. Ball, Dario J. Englot, Sarah K. Bick
  Stereotactic and Functional Neurosurgery.2024; 102(3): 179.     CrossRef
• Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
  Eui-Hwan Choi, Mi-Hye Kim, Sun-Ji Park
  International Journal of Molecular Sciences.2024; 25(14): 7952.     CrossRef
• Suppression of Glioblastoma Stem Cell Potency and Tumor Growth via LRRK2 Inhibition
  Saewhan Park, Kyung-Hee Kim, Yun-Hee Bae, Young Taek Oh, Hyemi Shin, Hyung Joon Kwon, Chan Il Kim, Sung Soo Kim, Hwan-Geun Choi, Jong Bae Park, Byoung Dae Lee
  International Journal of Stem Cells.2024; 17(3): 319.     CrossRef
• Genetic heterogeneity of early onset Parkinson disease: The dilemma of clinico-genetic correlation
  Roopa Rajan, Vikram V. Holla, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal
  Parkinsonism & Related Disorders.2024; 129: 107146.     CrossRef
• Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
  Diego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, Maria J. Feal Painceiras, Maria Cristina Íñiguez-Alvarado, Iago García Díaz, Silvia Jesús, Maria Teresa Buongiorno, Lluís Planellas, Marina Cosgaya, Juan García Caldentey, Nuria Caball
  Journal of Parkinson’s Disease.2023; 13(3): 379.     CrossRef
• To lump or to split? Deep brain stimulation may improve non-motor symptoms in certain Parkinson's disease subtypes
  Neepa Patel
  Parkinsonism & Related Disorders.2023; 109: 105369.     CrossRef
• Emerging Roles of Signal Transduction Pathways in Neurodegenerative Diseases. Hunting New Possible Therapeutic Molecular Targets
  Vincenza Rita Lo Vasco
  OBM Geriatrics.2023; 07(02): 1.     CrossRef
• Genome- and Exome-Wide Association Studies Revealed Candidate Genes Associated with DaTscan Imaging Features
  Arash Yaghoobi, Homa Seyedmirzaei, Moein Ala, Cristine Alves da Costa
  Parkinson's Disease.2023; 2023: 1.     CrossRef
• Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
  Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
  Brain Sciences.2023; 13(10): 1471.     CrossRef
• Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson’s disease and monogenic dystonia: a multidisciplinary team perspective
  Valentino Rački, Mario Hero, Eliša Papić, Gloria Rožmarić, Nada Starčević Čizmarević, Darko Chudy, Borut Peterlin, Vladimira Vuletić
  Frontiers in Neuroscience.2023;[Epub]     CrossRef
• PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy
  Tinh Thi Nguyen, Yun Joong Kim, Thuy Thi Lai, Phuong Thi Nguyen, Young Ho Koh, Linh Thi Nhat Nguyen, Hyeo-il Ma, Young Eun Kim
  Journal of Parkinson's Disease.2022; 12(4): 1201.     CrossRef
• Oncogenic Pathways in Neurodegenerative Diseases
  Luis Varela, Maria E. R. Garcia-Rendueles
  International Journal of Molecular Sciences.2022; 23(6): 3223.     CrossRef
• Genetic Determinants of Survival in Parkinson's Disease in the Asian Population
  Chunyu Li, Yanbing Hou, Ruwei Ou, Xiaojing Gu, Yongping Chen, Lingyu Zhang, Kuncheng Liu, Junyu Lin, Bei Cao, Qianqian Wei, Xueping Chen, Wei Song, Bi Zhao, Ying Wu, Yiyuan Cui, Huifang Shang
  Movement Disorders.2022; 37(8): 1624.     CrossRef
• Obituary for Jan O. Aasly (1950–2022)
  Matthew J. Farrer
  Movement Disorders.2022; 37(9): 1783.     CrossRef
• Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicine
  Mohamed Aborageh, Peter Krawitz, Holger Fröhlich
  Frontiers in Molecular Medicine.2022;[Epub]     CrossRef
• Recent developments in nucleic acid-based therapies for Parkinson’s disease: Current status, clinical potential, and future strategies
  Shivam Kumar Pandey, Rakesh Kumar Singh
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM study
  Daniel Weiss, Zied Landoulsi, Patrick May, Manu Sharma, Michael Schüpbach, Hana You, Jean Christophe Corvol, Steffen Paschen, Ann-Kristin Helmers, Michael Barbe, Gereon Fink, Andrea A. Kühn, Christine Brefel Courbon, Lars Wojtecki, Philippe Damier, Valeri
  Parkinsonism & Related Disorders.2022; 103: 169.     CrossRef
• Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase 1 Influenced the Age Onset of Parkinson's Disease
  Nóra Török, Rita Maszlag-Török, Kinga Molnár, Zoltán Szolnoki, Ferenc Somogyvári, Krisztina Boda, Masaru Tanaka, Péter Klivényi, László Vécsei
  Frontiers in Bioscience-Landmark.2022;[Epub]     CrossRef
• Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
  Jan O. Aasly
  Frontiers in Neuroscience.2021;[Epub]     CrossRef
• Increased Mortality in Young-Onset Parkinson’s Disease
  Eldbjørg Hustad, Tor Åge Myklebust, Sasha Gulati, Jan O. Aasly
  Journal of Movement Disorders.2021; 14(3): 214.     CrossRef
• Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort
  Sylvia Binck, Claire Pauly, Michel Vaillant, Geraldine Hipp, Manon Gantenbein, Rejko Krueger, Nico J Diederich
  Frontiers in Neurology.2020;[Epub]     CrossRef